查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641385

全球橫向流動分析市場：特色見解（2025-2030年）

Global Lateral Flow Assays Market - Focused Insights 2025-2030
出版日期: | 出版商: Arizton Advisory & Intelligence | 英文 155 Pages | 訂單完成後即時交付

價格

估計2024年至2023年期間全球橫向流動分析市場規模的年複合成長率為 3.20%。

2024年，試劑盒和試劑市場領域佔據最大的市場佔有率。該行業的成長主要歸功於技術發展和不斷進步。夾層分析法顯示 3.56%的高成長率，因其適用於檢測具有多個結合位點的較大分析物。臨床診斷領域佔比最大，為45%。由於慢性和非慢性疾病的發生率不斷上升，橫向流動分析在臨床診斷中的應用與其他行業相比明顯更高。醫院和診所佔據最大的市場。醫院和診所將 LFA 技術用於篩檢、診斷、監測、預測和監視等多種應用，促進該領域的發展。

2024年，北美佔據全球橫向流動分析市場的最大佔有率，佔比超過 25%。該地區在臨床診斷、環境科學、食品工業和獸醫學等領域的成熟市場是該成長的主要驅動力。由於 LFA 讀取器的發展以及對將智慧型手機和 AI 整合到 LFA 的關注度不斷提高，全球橫向流動分析市場預計將實現成長。

橫向流動分析（LFA）是一種即時檢測平台，數十年來已廣泛應用於臨床診斷和環境應用。先進奈米材料在 LFA 中的應用引領了產業發展，顯著提高了 LFA 的性能，使各種應用中的物質檢測更加可靠。將奈米粒子（NPs）整合到 LAF 中可以幫助解決即時診斷中的多項挑戰，包括降低檢測極限、提高靈敏度、多路復用和分析物的量化。目前，利用光學金屬奈米粒子（例如碳奈米粒子、金奈米粒子（Au NPs）、量子點（QDs）和上轉換奈米粒子）已經提高了 LFA 診斷的效率和便利性。其中，金奈米粒子（Au NPs）由於其優異的光學性能和化學穩定性，是目前最受歡迎且是LFA中最常用的光學奈米粒子之一。

供應商不斷改進 LFA 的新技術和試劑，以提高準確性和靈敏度。此外，光聲技術、表面增強拉曼光譜（SERS）、智慧型手機與數位熱讀取器的整合以及螢光共振能量轉移（FRET）等多項新技術最近也紛紛出現在市場上，成為LFA產業前景看好的熱門技術。這些技術提高了LFA的準確性和靈敏度。在COVID-19疫情期間，對高靈敏度LFA的需求增加為SERS技術創造了有利的機會。血清樣本的高特異性使得SERS成為診斷傳染病的有效醫療工具。此外，這項新技術還具有便攜性、數位分析、30 分鐘內快速獲得結果以及適用於多種工業應用的多功能性。

本報告概述了全球橫向流動分析市場，包括產品、技術、應用、最終用戶和地區的趨勢，以及參與市場的公司概況。

目錄

第1章 橫向流動分析市場競爭格局概論

  • 執行摘要
  • 主要調查結果

第2章 橫向流動分析市場競爭格局

  • 全球：橫向流動分析市場收入預測（2021-2030年，十億美元）

第3章 橫向流動分析市場的前景與機會

  • 橫向流動分析市場機會與趨勢
  • 橫向流動分析市場驅動因素
  • 限制橫向流動分析市場的因素

第4章 橫向流動分析市場區隔資料

  • 全球：依產品劃分的收入預測（2021-2030年，十億美元）
  • 全球：依技術劃分的收入預測（2021-2030年，十億美元）
  • 全球：依應用劃分的預測收入（2021-2030年，十億美元）
  • 全球：依最終用戶預測的收入（2021-2030年，十億美元）

第5章 主要地區概況

  • 北美：橫向流動分析市場收入預測（2021-2030年，十億美元）
    • 美國
    • 加拿大
  • 歐洲：橫向流動分析市場收入預測（2021-2030年，十億美元）
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 西班牙
  • 亞太地區：橫向流動分析市場收入預測（2021-2030年，十億美元）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
  • 拉丁美洲：橫向流動分析市場收入預測（2021-2030年，十億美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東與非洲：橫向流動分析市場收入預測（2021-2030年，十億美元）
    • 土耳其
    • 沙烏地阿拉伯
    • 南非

第6章 橫向流動分析市場產業概況

  • 橫向流動分析市場 - 競爭格局
  • 橫向流動分析市場 - 主要供應商概況
  • 橫向流動分析市場 - 其他主要供應商
  • 橫向流動分析市場 - 主要策略建議

第7章 附錄

Product Code: AFI24192

The global lateral flow assay market is expected to grow at a CAGR of 3.20% from 2024 to 20230.

KEY TAKEAWAYS

  • By Product: In 2024, the kits & reagents market segment accounted for the largest market share. The segmental growth is mainly attributed to the technology development and continued advancement.
  • By Technique: The sandwich assay segment shows the highest growth of 3.56% as they help to detect larger analytes with multiple binding sites.
  • By Application: The clinical diagnostics segment holds the largest market share of 45%. The application of lateral flow assays in clinical diagnostics is significantly high compared to other industries due to the growing prevalence of chronic and non-chronic diseases.
  • By End-Users: The hospitals and clinics segment holds the largest market share. In hospitals and clinics, the LFA technique is used in a range of applications, including screening, diagnosis, monitoring, prognosis, and surveillance, thus helping segmental growth.
  • By Geography: In 2024, North America held the largest share of over 25% in the global lateral flow assays market. The region's well-established markets in clinical diagnostics, environmental science, the food industry, and veterinary care are key drivers of this growth.
  • Growth Factor: The global lateral flow assays market is set to grow due to attention toward the development of LFAs readers and the integration of smartphones and AI in LFAs.

MARKET OPPORTUNITIES & DRIVERS

Next-generation Lateral Flow Assay

Lateral flow assay (LFA) is a widely used point-of-care platform in clinical diagnostic and environmental applications from several decades ago. The adoption of advanced nanomaterials in LFAs is driving the industry forward by significantly enhancing their performance, making them more reliable for detecting substances in diverse applications. The integration of nanoparticles (NPs) in LAFs helps to address several challenges of point-of-care diagnostics, such as lowering the detection limits, sensitivity enhancement, multiplexing, and quantification of analytes. Currently, the efficiency and convenience of LFA diagnosis have been improved using some optical metal nanoparticles, such as carbon NPs, gold NPs (Au NPs), quantum dots (QD), and up-conversion NPs. Of these, owing to excellent optical properties and chemical stability, gold NPs (Au NPs) have now become the most popular and one of the most used optical nanometers in LFA.

Advancement in Lateral Flow Assay Solutions and Reagents

New technologies and reagents in LFAs are continuously advancing and improving accuracy and sensitivity by vendors. In addition, some new technologies have recently emerged in the market, such as photoacoustic techniques, Surface-enhanced Raman Spectroscopy (SERS), integration of smartphones and digital thermal readers, and fluorescence resonance energy transfer (FRET) have become promising and popular technologies in LFAs industry. These technologies are enabling more accuracy and increasing sensitivity of LFAs. During the COVID-19 pandemic, the increasing demand for high-sensitivity LFAs created lucrative opportunities for SERS technology. With high specificity in the serum sample, SERS becomes an effective medical device for diagnosing infectious diseases. Furthermore, this new technology offers more portability, digital analysis, rapid result delivery within 30 minutes, and versatility in use across several industrial applications.

Rising Acceptance of Point-of-care (POC) Testing

The point-of-care-testing (POCT) approach has expanded itself as having remarkable values in the diagnosis of infectious diseases as well as non-communicable diseases. Where, POCT has succeeded in meeting the current need for diagnostic strategies that can offer reliable, sensitive, fast, and highly accurate test results without incorporating complex procedures. This increasing demand has been accomplished by developing rapid bioanalytical sensors or tools such as Lateral Flow Assays (LFAs). The application of POCT in infectious disease diagnosis is well-known across the healthcare industry. However, its growing application in chronic diseases, such as cancer, stroke, diabetes, and Alzheimer's fuels significant market growth. The growing mortality of these non-communicable diseases drives the significant demand for POCT.

INDUSTRY RESTRAINTS

Limitations of Lateral Flow Assays

Lateral flow assay is a widely used solution across healthcare and other industries, and it gained high momentum in recent years. However, it also has some limitations, such as low resolution, they are unable to control the flow rate, and demand for large volumes of reagents creating huge imitations in their usage. Many LFIAs are designed for point-of-care/as-needed use, providing inexpensive, quick, and easy testing that is desirable in many industries. However, regulators often need to confirm results using independent methods. Therefore, LFIA is only suitable for primary point-of-care/as-needed screening. With a long shelf life and no refrigeration required for storage, these tests are well-suited for use in developing countries. Lateral flow (antigen) testing is widely used to enroll children in schools and kindergartens for SARS-CoV-2, the virus that causes COVID-19 infection. The accuracy of these tests in adults varies widely and is often much lower than specified by the manufacturer.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT

The global lateral flow assay market by product is segmented into kits & reagents and readers. The kits & reagents accounted for the largest market share in 2024. These kits and reagents, including biomarkers, assay kits, substrates, enzymes, specific proteins, lipids, and other test kits, are essential for obtaining quick and accurate results in diagnosing acute and chronic diseases. Segmental growth is primarily driven by continuous technological advancements, with lateral flow assay (LFA) kits becoming increasingly sophisticated through the integration of new technologies. These advancements create significant opportunities for market expansion. LFA kits are widely used for rapid and early detection of health conditions such as pregnancy, infectious diseases, blood glucose levels, and more. The rising prevalence of infectious and chronic diseases, coupled with the growing use of LFAs in women's health such as pregnancy and fertility testing contributes to the segment's robust growth.

By Product

  • Kits & Reagent
  • Readers

INSIGHTS BY TECHNIQUE

The global lateral flow assay market by technique is categorized into sandwich assays and competitive assays. The sandwich assays show significant growth, with the fastest-growing CAGR of 3.56% during the forecast period. A sandwich assay is a non-competitive lateral flow assay commonly used to detect larger analytes with multiple binding sites. It is the most widely used assay technique in LFA. Some of its key applications include pregnancy test kits and COVID-19 rapid test kits. In the US, over 20 million pregnancy test kits are sold annually. In 2020, the World Health Organization facilitated the distribution of approximately 120 million COVID-19 rapid test kits globally. Furthermore, the sandwich assay is typically used to detect antigens from biological fluids, such as saliva, or pathogenic substances in food samples or genetically modified crops. Its wide range of applications spans human and veterinary clinical diagnostics, food safety, and the agriculture sector, driving significant growth in this segment.

By Technique

  • Sandwich Assays
  • Competitive Assays

INSIGHTS BY APPLICATIONS

Based on the applications, the clinical diagnostics segment dominates and holds the largest share of the global lateral flow assay market in 2024. The application of lateral flow assays (LFAs) in clinical diagnostics is significantly higher compared to other industries. With the growing prevalence of chronic and non-chronic diseases, the demand for LFA-based point-of-care testing is continuously increasing across the global healthcare industry.

The use of LFAs for infectious disease diagnosis was well-established before the pandemic. However, the surge in COVID-19 infections has made LFAs one of the most critical tools in clinical diagnostics worldwide. The ability to rapidly diagnose infectious diseases has been identified as a strategic priority by various organizations. For instance, the Health and Human Services (HHS), the National Institutes of Health (NIH), the US Centers for Disease Control and Prevention (CDC), and the US Department of Defense (DoD) consider rapid and early detection essential to mitigating the impact of infectious diseases on populations.

By Applications

  • Clinical Diagnostics
  • Food Safety
  • Veterinary Diagnostics
  • Other Applications

INSIGHTS BY END-USERS

Based on the end-users, in 2024, the hospitals and clinics segment holds the largest market share. In hospitals and clinics, the lateral flow assay (LFA) technique is used in a wide range of applications, including screening, diagnosis, monitoring, prognosis, and surveillance. Globally, the significant prevalence of various communicable and non-communicable diseases has led to an increasing demand for hospital admissions and clinical visits. From disease diagnosis to patient monitoring, LFAs play a vital role in supporting these operations. As an affordable, versatile, and reliable technique, LFAs are driving substantial market growth, with hospitals and clinics contributing significantly. Moreover, these facilities support clinical testing and research activities. Since hospitals are ideal settings for conducting clinical research, LFAs are commonly utilized in such environments. Additionally, hospital-associated diagnostics and pathology labs contribute significantly to market revenue growth. Nearly all hospitals have their clinical diagnostic labs, which generate a substantial demand for LFAs.

By End-Users

  • Hospitals & Clinics
  • Home Healthcare
  • Diagnostic Laboratories
  • Food & Beverages Companies
  • Pharma & Biotech Companies
  • Other End-user

GEOGRAPHICAL ANALYSIS

In 2024, North America held the largest share of over 25% in the global lateral flow assay market. North America is a well-developed market for clinical diagnostics, environmental science, the food industry, and veterinary care, all of which significantly drive market growth in the region. The availability of advanced clinical diagnostic services and the widespread adoption of point-of-care testing strategies in the healthcare industry fuel the demand for LFAs. Self-diagnosis is a widely adopted approach in North America's healthcare sector. Beyond healthcare, industries such as environmental science, food production, and veterinary diagnostics also play major roles in driving market growth. In Canada, veterinary care is in high demand, while in the US, the veterinary industry is rapidly expanding due to increasing pet ownership and a growing population of farm animals. The food industry is also experiencing significant growth in both the US and Canada. This growth, coupled with stringent food safety regulations, has created a substantial demand for LFAs in food safety testing. As the food industry expands, regulatory norms continue to tighten to ensure food safety, further boosting the need for lateral flow assays.

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Russia
    • Spain
  • APAC
    • India
    • China
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

COMPETITIVE LANDSCAPE

The global lateral flow assays market report consists of exclusive data on 36 vendors. Abbott Laboratories, F. Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, QuidelOrtho Corporation, and PerkinElmer are some of the leading companies accounting for the largest share of the global lateral flow assays market. These vendors are continuously focusing on expanding their lateral flow assay solutions and services that meet customers' requirements and international regulations, as well as increasing the efficiency of their products and strengthening their market position. Also, the adoption of various strategies, such as product launches, and new product development with advanced technologies, by key and other prominent players intensified the competition in the market. The adoption of such strategies by the major market players and their focus on expanding their capabilities have enabled them to gain a higher revenue share in the market. In 2024, Gold Standard Diagnostics announced the launch of a new allergen PowerLine Test: SENSIStrip Gluten Powerline Lateral Flow Device for food safety applications.

Key Vendors

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • QuidelOrtho Corporation
  • PerkinElmer

Other Prominent Vendors

  • Abingdon Health
  • Access Bio
  • Arbor Vita
  • Assure Tech
  • Atomo Diagnostics
  • Milenia Biotec
  • AccuBioTech
  • BD
  • BIOMERIEUX
  • bioLytical Laboratories
  • Bio-Rad Laboratories
  • BIOSYNEX TECHNOLOGIES GmbH
  • Cupid Limited
  • DIALAB
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • INTEC
  • J. Mitra & Co. Pvt. Ltd.
  • KHB
  • Meril Life Sciences
  • Merck KGaA
  • MP Biomedicals
  • Medsource Ozone Biomedicals
  • Nanjing Synthgene Medical Technology
  • QIAGEN
  • Rega Biotechnology
  • SD Biosensor
  • Turklab A. S.
  • Trinity Biotech
  • Wondfo
  • Gold Standard Diagnostics

KEY QUESTIONS ANSWERED:

1. How big is the global lateral flow assays market?

2. What is the growth rate of the global lateral flow assays market?

3. What are the factors driving the global lateral flow assays market growth?

4. Which are the leading and rapidly growing application areas for lateral flow assay?

5. Who are the major players in the global lateral flow assays market?

TABLE OF CONTENTS

CHAPTER - 1: Competitive Landscape of Lateral Flow Assays Market Overview

  • Executive Summary
  • Key Findings

CHAPTER - 2: Competitive Landscape of Lateral Flow Assays Market

  • GLOBAL: Projected Revenue of Lateral Flow Assays Market (2021-2030; $ Billions)

CHAPTER - 3: Lateral Flow Assays Market Prospects & Opportunities

  • Lateral Flow Assays Market Opportunities & Trends
  • Lateral Flow Assays Market Drivers
  • Lateral Flow Assays Market Constraints

CHAPTER - 4:Lateral Flow Assays Market Segmentation Data

  • GLOBAL: Projected Revenue by Product (2021-2030; $ Billions)
    • Kits & Reagents
    • Readers
  • GLOBAL: Projected Revenue by Technique (2021-2030; $ Billions)
    • Sandwich Assays
    • Competitive Assays
  • GLOBAL: Projected Revenue by Applications (2021-2030; $ Billions)
    • Clinical Diagnostics
    • Food Safety
    • Veterinary Diagnostics
    • Other Applications
  • GLOBAL: Projected Revenue by End-user (2021-2030; $ Billions)
    • Hospitals & Clinics
    • Home Healthcare
    • Diagnostic Laboratories
    • Food & Beverages Companies
    • Pharma & Biotech Companies

CHAPTER - 5: Key Regions Overview

  • North America: Projected Revenue of Lateral Flow Assays Market (2021-2030; $ Billions)
    • Projected Revenue of Lateral Flow Assays Market in the US
    • Projected Revenue of Lateral Flow Assays Market in Canada
  • Europe: Projected Revenue of Lateral Flow Assays Market (2021-2030; $ Billions)
    • Projected Revenue of Lateral Flow Assays Market in the UK
    • Projected Revenue of Lateral Flow Assays Market in France
    • Projected Revenue of Lateral Flow Assays Market in Germany
    • Projected Revenue of Lateral Flow Assays Market in Italy
    • Projected Revenue of Lateral Flow Assays Market in Russia
    • Projected Revenue of Lateral Flow Assays Market in Spain
  • APAC: Projected Revenue of Lateral Flow Assays Market (2021-2030; $ Billions)
    • Projected Revenue of Lateral Flow Assays Market in India
    • Projected Revenue of Lateral Flow Assays Market in China
    • Projected Revenue of Lateral Flow Assays Market in Japan
    • Projected Revenue of Lateral Flow Assays Market in South Korea
    • Projected Revenue of Lateral Flow Assays Market in Australia
  • Latin America: Projected Revenue of Lateral Flow Assays Market (2021-2030; $ Billions)
    • Projected Revenue of Lateral Flow Assays Market in Brazil
    • Projected Revenue of Lateral Flow Assays Market in Mexico
    • Projected Revenue of Lateral Flow Assays Market in Argentina
  • Middle East & Africa: Projected Revenue of Lateral Flow Assays Market (2021-2030; $ Billions)
    • Projected Revenue of Lateral Flow Assays Market in Turkey
    • Projected Revenue of Lateral Flow Assays Market in Saudi Arabia
    • Projected Revenue of Lateral Flow Assays Market in South Africa

CHAPTER - 6: Lateral Flow Assays Market Industry Overview

  • Lateral Flow Assays Market - Competitive Landscape
  • Lateral Flow Assays Market- Key Vendor Profiles
  • Lateral Flow Assays Market- Other Prominent Vendors
  • Lateral Flow Assays Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

  • Research Methodology
  • Abbreviations
  • About Arizton

LIST OF EXHIBITS

  • Exhibit 1: Projected Revenues of Lateral Flow Assays Market in Global (2021 - 2030; $ BN)
  • Exhibit 2: Market Size & Forecast - Kits & Reagent (2021 - 2030; $ BN)
  • Exhibit 3: Market Size & Forecast - Readers (2021 - 2030; $ BN)
  • Exhibit 4: Market Size & Forecast - Sandwich Assays (2021 - 2030; $ BN)
  • Exhibit 5: Market Size & Forecast - Competitive Assays (2021 - 2030; $ BN)
  • Exhibit 6: Market Size & Forecast - Clinical Diagnostics (2021 - 2030; $ BN)
  • Exhibit 7: Market Size & Forecast - Food Safety (2021 - 2030; $ BN)
  • Exhibit 8: Market Size & Forecast - Veterinary Diagnostics (2021 - 2030; $ BN)
  • Exhibit 9: Market Size & Forecast - Other Applications (2021 - 2030; $ BN)
  • Exhibit 10: Market Size & Forecast - Hospitals & Clinics (2021 - 2030; $ BN)
  • Exhibit 11: Market Size & Forecast - Home Healthcare (2021 - 2030; $ BN)
  • Exhibit 12: Market Size & Forecast - Diagnostics Laboratories (2021 - 2030; $ BN)
  • Exhibit 13: Market Size & Forecast - Food & Beverages Companies (2021 - 2030; $ BN)
  • Exhibit 14: Market Size & Forecast - Pharma & Biotech Companies (2021 - 2030; $ BN)
  • Exhibit 15: Market Size & Forecast - Other End-user (2021 - 2030; $ BN)
  • Exhibit 16: Projected Revenues of Lateral Flow Assays Market in N. America (2021 - 2030; $ BN)
  • Exhibit 17: Projected Revenues of Lateral Flow Assays Market in the US (2021 - 2030; $ BN)
  • Exhibit 18: Projected Revenues of Lateral Flow Assays Market in Canada (2021 - 2030; $ BN)
  • Exhibit 19: Projected Revenues of Lateral Flow Assays Market in Europe (2021 - 2030; $ BN)
  • Exhibit 20: Projected Revenues of Lateral Flow Assays Market in the UK (2021 - 2030; $ BN)
  • Exhibit 21: Projected Revenues of Lateral Flow Assays Market France (2021 - 2030; $ BN)
  • Exhibit 22: Projected Revenues of Lateral Flow Assays Market in Germany (2021 - 2030; $ BN)
  • Exhibit 23: Projected Revenues of Lateral Flow Assays Market in Italy (2021 - 2030; $ BN)
  • Exhibit 24: Projected Revenues of Lateral Flow Assays Market in Russia (2021 - 2030; $ BN)
  • Exhibit 25: Projected Revenues of Lateral Flow Assays Market in Spain (2021 - 2030; $ BN)
  • Exhibit 26: Projected Revenues of Lateral Flow Assays Market in APAC (2021 - 2030; $ BN)
  • Exhibit 27: Projected Revenues of Lateral Flow Assays Market in India (2021 - 2030; $ BN)
  • Exhibit 28: Projected Revenues of Lateral Flow Assays Market in China (2021 - 2030; $ BN)
  • Exhibit 29: Projected Revenues of Lateral Flow Assays Market in Japan (2021 - 2030; $ BN)
  • Exhibit 30: Projected Revenues of Lateral Flow Assays Market in South Korea (2021 - 2030; $ BN)
  • Exhibit 31: Projected Revenues of Lateral Flow Assays Market in Australia (2021 - 2030; $ BN)
  • Exhibit 32: Projected Revenues of Lateral Flow Assays Market in L. America (2021 - 2030; $ BN)
  • Exhibit 33: Projected Revenues of Lateral Flow Assays Market in Brazil (2021 - 2030; $ BN)
  • Exhibit 34: Projected Revenues of Lateral Flow Assays Market in Mexico (2021 - 2030; $ BN)
  • Exhibit 35: Projected Revenues of Lateral Flow Assays Market in Argentina (2021 - 2030; $ BN)
  • Exhibit 36: Projected Revenues of Lateral Flow Assays Market in MEA (2021 - 2030; $ BN)
  • Exhibit 37: Projected Revenues of Lateral Flow Assays Market in Turkey (2021 - 2030; $ BN)
  • Exhibit 38: Projected Revenues of Lateral Flow Assays Market in Saudi Arabia (2021 - 2030; $ BN)
  • Exhibit 39: Projected Revenues of Lateral Flow Assays Market in South Africa (2021 - 2030; $ BN)

LIST OF TABLES

  • Table 1: Projected Revenues of Global Lateral Flow Assays Market (2021 - 2030; $ BN)
  • Table 2: Market Size & Forecast - Product (2021 - 2030; $ BN)
  • Table 3: Market Size & Forecast - Product (2021 - 2030; %)
  • Table 4: Market Size & Forecast - Technique (2021 - 2030; $ BN)
  • Table 5: Market Size & Forecast - Technique - (2021 - 2030; %)
  • Table 6: Market Size & Forecast - Application (2021 - 2030; $ BN)
  • Table 7: Market Size & Forecast - Application - (2021 - 2030; %)
  • Table 8: Market Size & Forecast - End-user (2021 - 2030; $ BN)
  • Table 9: Market Size & Forecast - End-user (2021 - 2030; %)
  • Table 10: Market Size & Forecast - Geography (2021 - 2030, $ BN)
  • Table 11: Market Size & Forecast - Geography (2021 - 2030; %)